As of 2025-11-02, the Intrinsic Value of Solid Biosciences Inc (SLDB) is -9.89 USD. This SLDB valuation is based on the model Peter Lynch Fair Value. With the current market price of 5.39 USD, the upside of Solid Biosciences Inc is -283.56%.
Based on its market price of 5.39 USD and our intrinsic valuation, Solid Biosciences Inc (SLDB) is overvalued by 283.56%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -9.89 - -9.89 | -9.89 | -283.56% |
| P/E | (14.17) - (25.37) | (18.85) | -449.7% |
| DDM - Stable | (17.70) - (67.04) | (42.37) | -886.1% |
| DDM - Multi | (0.24) - (0.67) | (0.35) | -106.5% |
| Market Cap (mil) | 419.72 |
| Beta | 1.88 |
| Outstanding shares (mil) | 77.87 |
| Enterprise Value (mil) | 281.74 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.24% |
| Cost of Debt | 5.00% |
| WACC | 9.22% |